In early-stage adenomas, TGF-β1 functions as a tumor suppressor in normal epithelia by inhibiting cell growth and it is also one of the key cytokines in promoting EMT during embryonic development and during the late stages of cancer progression, leading to tumor cell invasiveness and metastasis. Here, TGFB1 is linked to adenoma.